BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CM512 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of CM512\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07011524-1337@assetmemo.bio
DTSTAMP:20261121T004545Z
DTSTART;VALUE=DATE:20270721
DTEND;VALUE=DATE:20270722
SUMMARY:CM512: Phase 2 readout est. (NCT07011524)
DESCRIPTION:CM512\, phase 2\, Asthma.\nStudy: Study of CM512 Injection in S
 ubjects With Moderate-to-severe Asthma\nEstimated primary completion: 21 J
 uly 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout 
 date\, and it can move.\nDrug page: https://assetmemo.bio/drug/cm512#upcom
 ing-events\nRegistry record: https://clinicaltrials.gov/study/NCT07011524
URL:https://assetmemo.bio/drug/cm512#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07807826-1337@assetmemo.bio
DTSTAMP:20261121T004545Z
DTSTART;VALUE=DATE:20271130
DTEND;VALUE=DATE:20271201
SUMMARY:CM512: Phase 3 readout est. (NCT07807826)
DESCRIPTION:CM512\, phase 3.\nStudy: A Study of CM512 in Patients With Chro
 nic Rhinosinusitis With Nasal Polyposis (NEZHA-3)\nEstimated primary compl
 etion: November 2027. This is a ClinicalTrials.gov estimate\, not a confir
 med readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug
 /cm512#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/
 NCT07807826
URL:https://assetmemo.bio/drug/cm512#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07230483-1337@assetmemo.bio
DTSTAMP:20261121T004545Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:CM512: Phase 2 readout est. (NCT07230483)
DESCRIPTION:CM512\, phase 2\, Atopic Dermatitis.\nStudy: A Long-term Safety
  and Efficacy Study Evaluating CM512 in Atopic Dermatitis.\nEstimated prim
 ary completion: December 2027. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/cm512#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT07230483
URL:https://assetmemo.bio/drug/cm512#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06980142-1337@assetmemo.bio
DTSTAMP:20261121T004545Z
DTSTART;VALUE=DATE:20280317
DTEND;VALUE=DATE:20280318
SUMMARY:CM512: Phase 2 readout est. (NCT06980142)
DESCRIPTION:CM512\, phase 2\, Chronic Obstructive Pulmonary Disease.\nStudy
 : A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive
  Pulmonary Disease\nEstimated primary completion: 17 March 2028. This is a
  ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can m
 ove.\nDrug page: https://assetmemo.bio/drug/cm512#upcoming-events\nRegistr
 y record: https://clinicaltrials.gov/study/NCT06980142
URL:https://assetmemo.bio/drug/cm512#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07519577-1337@assetmemo.bio
DTSTAMP:20261121T004545Z
DTSTART;VALUE=DATE:20280531
DTEND;VALUE=DATE:20280601
SUMMARY:CM512: Phase 2 readout est. (NCT07519577)
DESCRIPTION:CM512\, phase 2.\nStudy: A Study of CM512 in Patients With Chro
 nic Rhinosinusitis With Nasal Polyposis （NEZHA-2）\nEstimated primary c
 ompletion: 31 May 2028. This is a ClinicalTrials.gov estimate\, not a conf
 irmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dr
 ug/cm512#upcoming-events\nRegistry record: https://clinicaltrials.gov/stud
 y/NCT07519577
URL:https://assetmemo.bio/drug/cm512#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07890350-1337@assetmemo.bio
DTSTAMP:20261121T004545Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:CM512: Phase 2 readout est. (NCT07890350)
DESCRIPTION:CM512\, phase 2.\nStudy: Study of CM512 Injection in Patients W
 ith Perennial Allergic Rhinitis on Background Therapy\nEstimated primary c
 ompletion: June 2028. This is a ClinicalTrials.gov estimate\, not a confir
 med readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug
 /cm512#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/
 NCT07890350
URL:https://assetmemo.bio/drug/cm512#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
